Table 2.
Comparison of NMS severity in patients with a PD disease duration of less than 10 years.
| Mean | P value | |||||
|---|---|---|---|---|---|---|
| Group 1 (0–2 years) | Group 2 (2–4 years) | Group 3 (4–6 years) | Group 4 (6–8 years) | Group 5 (8–10 years) | ||
| Total score of NMSS | 26.01 | 31.63 | 36.29 | 37.37 | 47.67 | 0.000** |
| Cardiovascular | 1.37 | 1.38 | 1.8 | 2.24 | 2.12 | 0.192 |
| Sleep/fatigue | 6.04 | 6.3 | 6.89 | 6.4 | 9.27 | 0.093 |
| Mood/cognition | 4.24 | 6.49 | 6.6 | 6.13 | 7.03 | 0.329 |
| Perceptual problems/hallucination | 0.24 | 0.38 | 0.7 | 1.11 | 1.93 | 0.000** |
| Attention/memory | 3.44 | 3.72 | 4.57 | 4.46 | 6.63 | 0.008** |
| Gastrointestinal | 2.77 | 3.49 | 3.9 | 5.36 | 7.12 | 0.000** |
| Urinary | 4.54 | 5.88 | 6.57 | 6.59 | 7.03 | 0.170 |
| Sexual function | 1.01 | 0.82 | 1.7 | 1.35 | 1.9 | 0.087 |
| Miscellaneous | 2.36 | 3.18 | 3.57 | 3.73 | 4.63 | 0.033* |
Group 1: 0 to 2 years (n = 142); group 2: 2 to 4 years (n = 194); group 3: 4 to 6 years (n = 166); group 4: 6 to 8 years (n = 114); group 5: 8 to 10 years (n = 60). The mean values of each group are shown in the left 5 columns, and the P values calculated using one-way analysis of variance are shown in the last column. Age and sex were corrected. *P < .05; **P < .01.